keyword
MENU ▼
Read by QxMD icon Read
search

Oral Hemangioma

keyword
https://www.readbyqxmd.com/read/29106877/role-of-imaging-in-the-diagnosis-of-parotid-infantile-hemangiomas
#1
Fabiola C Weber, Arin K Greene, Denise M Adams, Marilyn G Liang, Mohammed H Alomari, Stephan D Voss, Gulraiz Chaudry
OBJECTIVES: To review the clinical presentation, imaging and follow-up of parotid infantile hemangiomas (IH). METHODS: Over a 15-year period, all patients with a clinical diagnosis of parotid IH were evaluated. Imaging was available in 35. The medical records, photographs, and radiology studies of these patients were reviewed. RESULTS: All patients presented at less than 4 months of age (M:F, 13:21). 19 (55)% of tumors were on the left and were bilateral in 2 patients...
November 2017: International Journal of Pediatric Otorhinolaryngology
https://www.readbyqxmd.com/read/29103963/clinical-and-radiological-evaluation-of-periocular-infantile-hemangioma-treated-with-oral-propranolol-a-case-series
#2
Maria Antonieta Ginguerra, Osmar Saito, José Byron V D Fernandes, Deborah S Castro, Suzana Matayoshi
PURPOSE: Evaluate the efficacy of propranolol (3 mg/kg/day) in the treatment of periocular infantile hemangioma (IH) based on clinical and radiological findings. DESIGN: Prospective interventional case series METHODS: Study of previously untreated infants with IH conducted at the ophthalmology outpatient service of HC-FMUSP (Brazil). The patients were submitted to a complete ophthalmological examination, grey-scale and Doppler US, and nuclear MRI. Lesion regression was evaluated clinically and radiologically during follow-up...
November 2, 2017: American Journal of Ophthalmology
https://www.readbyqxmd.com/read/29073926/propranolol-in-the-preoperative-treatment-of-kasabach-merritt-syndrome-a-case-report
#3
Saša V Radović, Marija Kolinović, Darja Ljubić
BACKGROUND: Kasabach-Merritt syndrome represents the association of hemangioma with thrombocytopenia and consumptive coagulopathy. We present a case of Kasabach-Merritt syndrome treatment with orally administered propranolol. CASE PRESENTATION: A 4.5-month-old caucasian female infant with congenital giant hemangioma in the posterior region of her neck presented to our Institute for Childhood Diseases where she underwent clinical, laboratory, and radiological investigations...
October 27, 2017: Journal of Medical Case Reports
https://www.readbyqxmd.com/read/29053652/a-report-on-the-clinical-pathological-correlations-of-788-gingival-lesion
#4
A Gambino, M Carbone, R Broccoletti, P Carcieri, D Conrotto, M Carrozzo, P-G Arduino
BACKGROUND: The diagnosis and treatment of a variety of non-plaque related gingival diseases have become an integrated aspect of everyday dentistry. The aim of this study was to analyse the relationship between clinical appearance and histopathological features of gingival lesions in a large Northern Italian population. MATERIAL AND METHODS: A retrospective study of 788 cases of gingival and alveolar mucosal biopsies was set up. Statistical analysis was performed by calculating the odds ratio and 95% confidence interval (C...
November 1, 2017: Medicina Oral, Patología Oral y Cirugía Bucal
https://www.readbyqxmd.com/read/28991344/combined-oral-and-topical-beta-blockers-for-the-treatment-of-early-proliferative-superficial-periocular-infantile-capillary-hemangioma
#5
Hatem M Marey, Hesham F Elmazar, Sameh S Mandour, Hany A Khairy
PURPOSE: To evaluate the safety and efficacy of combined oral and topical beta blockers for the treatment of superficial periocular infantile hemangioma at the early proliferative stage. METHODS: This was a randomized, controlled comparison trial involving 25 patients. Patients were randomly enrolled into two groups: the topical and systemic treatment and systemic treatment only groups. The topical and systemic treatment group was treated with oral propranolol (1 mg/kg per day initially, increased to 2 mg/kg per day gradually in 2 weeks) and timolol maleate 0...
October 9, 2017: Journal of Pediatric Ophthalmology and Strabismus
https://www.readbyqxmd.com/read/28979336/a-24-week-treatment-of-pediatric-hemangioma-with-oral-propranolol
#6
Aziz Eghbali, Shabnam Hajiani, Bahman Sadeghi Sedeh, Abdolghader Pakniyat, Vahid Mansouri, Bahador Bagheri
Hemangioma is a benign vascular tumor that shouldbe treated in problematic situations.Propranolol efficacy, target dose, range of age, duration of treatment and complications arenot conclusive for treatment of pediatric hemangioma. Our goal was to study efficacy and safety of propranolol for hemangioma treating in children. A randomized, open label crossover trial with two twenty four-week treatment phases separated by a one-week washout period, was conducted in Amir-Kabir Hospital, Arak, Iran. Thirty two patients with age of 1 month to 15 years were randomized to receive either oral propranolol 2 mg/Kg/day or receivedno treatment...
2017: Iranian Journal of Pharmaceutical Research: IJPR
https://www.readbyqxmd.com/read/28968329/propranolol-treatment-of-vascular-anomalies-other-than-infantile-hemangioma
#7
Jeremy A Goss, Dennis J Konczyk, Mohammed H Alomari, Reid A Maclellan, Arin K Greene
BACKGROUND: Oral propranolol has become first-line intervention for problematic infantile hemangioma (IH) that is not amenable to topical or intralesional therapies. Consensus data supporting its efficacy for other vascular anomalies does not exist. The purpose of this study was to determine the frequency and causes of propranolol use for vascular lesions other than IH. METHODS: Referrals to our Vascular Anomalies Center between 2008 and 2017 were reviewed for patients treated with propranolol at an outside institution...
November 2017: Journal of Craniofacial Surgery
https://www.readbyqxmd.com/read/28955596/cavernous-lymphangioma-of-the-tongue-in-an-adult-a-case-report
#8
Selin Eren, Ahmet Taylan Cebi, Sabri Cemil Isler, Metin Berk Kasapoglu, Nihan Aksakalli, Cetin Kasapoglu
Lymphangioma is a benign hamartomatous lesion caused by congenital malformation of the lymphatic system. This benign tumor is detected most commonly at birth or in early childhood but rarely in adults. On clinical examination, most lymphangiomas contain clear lymph fluid, but some may present as transparent vesicles containing red blood cells due to hemorrhage. In addition, lymphangioma may occur in association with hemangioma. This tumor occurs most commonly in the head and neck area, but rarely in the oral cavity...
2017: J Istanb Univ Fac Dent
https://www.readbyqxmd.com/read/28903183/inhibition-of-hemangioma-growth-using-polymer-lipid-hybrid-nanoparticles-for-delivery-of-rapamycin
#9
Haitao Li, Yunfei Teng, Jin Sun, Jianyong Liu
Although infantile hemangiomas is benign, its rapid growth may induce serious complications. However, only one drug Hemangeol™ has been approved by US Food and Drug Administration (FDA) to treat infantile hemangiomas. Thus it is necessary to develop novel alternative drugs to treat infantile hemangiomas. Rapamycin is a well-know potent antiangiogenic agent, whereas the daily oral administration of rapamycin exerts undesired metabolic effects due to its inhibition of mechanistic target of rapamycin (mTOR) which is critical in cell metabolism...
November 2017: Biomedicine & Pharmacotherapy, Biomédecine & Pharmacothérapie
https://www.readbyqxmd.com/read/28836535/prevalence-and-pattern-of-lobular-capillary-hemangioma-in-eastern-madhya-pradesh-india-a-clinicopathological-analysis
#10
Divashree Sharma, Geeta Mishra Tripathi, Sourabh Dixit, Ajay Pillai, Shaji Thomas
BACKGROUND: Lobular capillary hemangioma is a common benign vascular tumor seen in the oral cavity. It occurs in response to various stimuli such as low-grade local irritation, traumatic insult, and hormonal factors or as a response to a wide variety of drugs. MATERIALS AND METHODS: All patients presenting to the Department of Dentistry, Shyam Shah Medical College, Rewa, Madhya Pradesh during July 2014 to June 2016, who were diagnosed by histopathologic confirmation as oral lobular capillary hemangioma (OLCH), were evaluated for the area involved, clinicopathologic presentation, demographic features, and treatment...
July 2017: Indian Journal of Dental Research: Official Publication of Indian Society for Dental Research
https://www.readbyqxmd.com/read/28813771/hepatic-adenoma-a-case-report
#11
Hasan H Turaihi, Thavam C Thambi-Pillai
Although liver lesions in the young population are relatively rare, clinicians can benefit from being familiar with a subset of common benign liver lesions which include hepatic adenoma, hepatic hemangioma, and focal nodular hyperplasia. This a case report of a 25-year-old Jehovah's Witness female on chronic oral contraception for polycystic ovarian syndrome who presented with progressive right upper quadrant abdominal pain. Ultrasound and MRI findings were consistent with hepatic adenoma. A description of her clinical work up followed by a brief description of the surgical intervention is discussed...
March 2017: South Dakota Medicine: the Journal of the South Dakota State Medical Association
https://www.readbyqxmd.com/read/28804922/study-of-cognitive-function-in-children-treated-with-propranolol-for-infantile-hemangioma
#12
Nieves González-Llorente, Isabel Del Olmo-Benito, Natalia Muñoz-Ollero, Miguel Angel Descalzo, Ignacio García-Doval, Antonio Torrelo
BACKGROUND: Oral propranolol is considered the first choice for the treatment of infantile hemangiomas (IHs). There is a concern that administering propranolol in newborns and infants could induce adverse effects in learning and memory processes in the long term. The purpose of this study was to assess cognitive and memory functions in children who had been treated with propranolol for IH during their infancy. METHODS: A total of 23 children between 5 and 7.5 years of age who had been treated with oral propranolol for IH during infancy were tested for cognitive functions with the Wechsler Preschool and Primary Scale of Intelligence, Fourth Edition (WPPSI-IV) test and for memory functions with the Test of Memory and Learning (TOMAL)...
August 14, 2017: Pediatric Dermatology
https://www.readbyqxmd.com/read/28719705/lobular-capillary-hemangioma-pyogenic-granuloma-of-the-oral-cavity
#13
Lester D Thompson
No abstract text is available yet for this article.
July 2017: Ear, Nose, & Throat Journal
https://www.readbyqxmd.com/read/28719370/simple-preparation-of-timolol-0-5-gel-from-eye-drop-solution-for-superficial-infantile-hemangiomas
#14
Winnie Choo
The discovery of beta-adrenergic blocker effects on infantile hemangiomas has affected the choice of treatment in recent years. Oral propranolol is effective in treating infantile hemangiomas, but the risk of systemic side effects remains a concern. Data from literature review reported positive clinical outcomes with no major adverse effects observed in children using topical beta-blocker such as timolol maleate. Topical application of timolol eye drop has been mentioned in few studies, most of which reported that the solution cannot stay on the site of application due to its fluidity...
July 2017: International Journal of Pharmaceutical Compounding
https://www.readbyqxmd.com/read/28708637/discussion-on-oral-propranolol-for-parotid-infantile-hemangiomas
#15
Kriya E Gishen, Seth R Thaller
No abstract text is available yet for this article.
July 13, 2017: Journal of Craniofacial Surgery
https://www.readbyqxmd.com/read/28702374/topical-application-of-0-5-timolol-maleate-hydrogel-for-the-treatment-of-superficial-infantile-hemangioma
#16
Hai Wei Wu, Chao Liu, Xuan Wang, Ling Zhang, Weien Yuan, Jia Wei Zheng, Li Xin Su, Xin Dong Fan
The therapeutic options for infantile hemangiomas (IHs) have been greatly altered since the introduction of oral propranolol for successful treatments of IHs. Recently, there is an increase in the application of topical timolol maleate for treating superficial IHs. In the present study, we developed a new formulation of timolol maleate 0.5% hydrogel and treated 321 patients with superficial IHs to evaluate its efficacy and safety in the treatment of superficial IHs. This new timolol hydrogel was applied three times daily with a mean duration of 7...
2017: Frontiers in Oncology
https://www.readbyqxmd.com/read/28660677/variability-of-delivery-of-timolol-for-the-treatment-of-infantile-hemangiomas
#17
JiaDe Yu, Tucker Keuter, Kala Schilter, Marcia Seefeldt, Brittney Bates, Katherine Mueller, Beth A Drolet
BACKGROUND/OBJECTIVES: Topical timolol maleate solution or gel-forming solution is used alone or in conjunction with oral propranolol for the treatment of infantile hemangiomas. The consistency of the amount of timolol dispensed has never been evaluated. We evaluated the variability of drug delivery between different brands and formulations of timolol solution and gel-forming solution. METHODS: Five blinded volunteers sequentially dispensed five drops from each of the eight bottles containing timolol 0...
July 2017: Pediatric Dermatology
https://www.readbyqxmd.com/read/28595986/oral-foregut-duplication-cysts-a-rare-and-fascinating-congenital-lesion-case-report-and-review-of-the-literature
#18
Kurt J Knowles, Juraj Berkovic, Anil Gungor, Majd Al Shaarani, Valerie Lockhart, Firas Al-Delphi, Elba A Turbat-Herrera
Oral foregut duplication cysts are extremely rare lesions with approximately 57 cases reported. They are congenital cysts, located in the anterior or ventral tongue, and occur predominantly in males. They are lined by one or more types of epithelia which is limited to gastric, intestinal or respiratory epithelium. The differential diagnosis includes lymphangioma, hemangioma, ranula, epidermoid cyst, teratoma and less likely a malignant process.
November 23, 2016: American Journal of Otolaryngology
https://www.readbyqxmd.com/read/28587325/sildenafil-suppresses-the-proliferation-and-enhances-the-apoptosis-of-hemangioma-endothelial-cells
#19
Xiaopo He, Yiran Liu, Kai Li, Aijun Yang, Rui Wang, Shaohua Liu
Treatment of infantile hemangiomas (IH) with propranolol was first reported in 2008. Regressions of lymphatic malformations combined with pulmonary hypertension was first reported in 2012 after three children received treatment with oral sildenafil, which serves as an antagonist of phosphodiesterase isoform-5 (PDE-5). A marked expression of endothelial cells in the cytoplasm of IH tissues was obtained in our previous study. Therefore, the present study hypothesized that the antagonist of PDE-5, sildenafil, may lead to the regression of hemangiomas...
June 2017: Experimental and Therapeutic Medicine
https://www.readbyqxmd.com/read/28566878/consequences-of-facial-hemangioma-with-regard-to-dental-treatment
#20
Gabriela Cristina Santin, Késsia Suênia Fidelis de Mesquita Guimarães, Sara Silva de Oliveira, Raquel Assed Bezerra da Silva, Paulo Nelson-Filho, Regina Guenka Palma-Dibb, Alexandra Mussolino de Queiroz
Hemangioma is a benign vascular tumor that affects 3%-10% of the population and usually does not require specific treatment due to spontaneous regression. The purpose of this paper is to present a case report of a child having been born prematurely and diagnosed with hemangioma in the head and neck, emphasizing the dentofacial changes and treatment used to provide care. Severe fibrous scars were found in the perioral region and below the ear that limited the patient's ability to open her mouth. The child exhibited anterior open bite as well as dental caries in the lower jaw, hypomineralization, and enamel hypoplasia...
January 2017: Contemporary Clinical Dentistry
keyword
keyword
107825
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"